Cargando…
L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact
The uptake transporter NaCT (gene symbol SLC13A5) is expressed in liver and brain and important for energy metabolism and brain development. Substrates include tricarboxylic acid cycle intermediates, e.g., citrate and succinate. To gain insights into the substrate spectrum of NaCT, we tested whether...
Autores principales: | Surrer, Daniela B., Fromm, Martin F., Maas, Renke, König, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026504/ https://www.ncbi.nlm.nih.gov/pubmed/35448460 http://dx.doi.org/10.3390/metabo12040273 |
Ejemplares similares
-
Structure and inhibition mechanism of the human citrate transporter NaCT
por: Sauer, David B., et al.
Publicado: (2021) -
The NACT Training Package
por: Scarpello, John H. B.
Publicado: (1991) -
Analysis of naturally occurring mutations in the human uptake transporter NaCT important for bone and brain development and energy metabolism
por: Selch, Stefan, et al.
Publicado: (2018) -
NACT+IMRT versus NACT+IMRT+CCRT in locoregionally advanced NPC patients: a retrospective study
por: Chen, Xialin, et al.
Publicado: (2019) -
Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)
por: Huard, Kim, et al.
Publicado: (2015)